2022 Ljubljana, Slovenia

II-10 Zhendong Chen
A Population Pharmacokinetic Model for Creatinine with and without ingestion of cooked meat
Wednesday 15:10-16:40
II-17 Nada Dia
Amikacin dose optimization in the emergency department: A population pharmaco-kinetic simulation study
Wednesday 15:10-16:40
II-24 Mourad HAMIMED
Population pharmacokinetics of cytarabine and its metabolite in patients with acute myeloid leukemia: effect of cytidine deaminase activity.
Wednesday 15:10-16:40
II-30 Heeyoung Kim
Model-based prediction of optimal dosing regimen of recombinant hepatitis B human immunoglobulin
Wednesday 15:10-16:40
II-43 Tim Preijers
Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID-19 ICU patients
Wednesday 15:10-16:40
II-49 Sebastiaan Sassen
A step towards automated and individualized first dose of vancomycin
Wednesday 15:10-16:40
II-52 Lea Marie Schatz
Model-informed Precision Dosing for vancomycin in children between 28 days and 18 years: Does the use of a multi-model approach improve the predictive performance?
Wednesday 15:10-16:40
II-56 Paul Thoueille
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration
Wednesday 15:10-16:40